Sarah A. Milgrom

ARS Appropriate Use Criteria voor extranodale NK/T-cellymfoom

Subsequent Neoplasm Risico After Modern Mediastinal Radiotherapie for Pediatric Hodgkin Lymphoma: Insights From a Multi-Institutional Children’s Oncology Group Trial

Enhancing Radiotherapie Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131

Multimodality Artificial Intelligence for Involved-Site Radiotherapie: Clinical Target Volume Delineation in High-Risico Pediatric Hodgkin Lymphoma